4DMedical Limited (ASX: 4DX) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
4DMedical Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
4DMedical Limited (ASX: 4DX)
Latest News
Share Gainers
Why 4DMedical, Iress, Premier Investments, and Tuas shares are pushing higher
Share Market News
Guess which ASX healthcare stock is rocketing on an 'unprecedented opportunity' with a global giant
Small Cap Shares
Guess why these small cap ASX shares are jumping 10%+ today
Healthcare Shares
This ASX medtech stock is roaring 67% higher today on a US approval
Small Cap Shares
3 exciting small cap ASX shares brokers are tipping as buys
Small Cap Shares
Bell Potter rates these small cap ASX shares as buys
Healthcare Shares
Guess which ASX medical share has exploded 275% in a month?
Share Gainers
5 top ASX shares that would have more than doubled your money in 2023
Healthcare Shares
Guess which ASX healthcare share is rocketing 67% on a US hospital deal
Share Gainers
In a sea of red, these ASX All Ords shares are leaping higher on Monday
Share Gainers
Why is the 4DMedical share price rocketing 20% on Wednesday?
Earnings Results
Why has the 4D Medical share price popped 7% in a month?
Frequently Asked Questions
-
No, 4DMedical does not pay dividends at this time.
-
4DMedical listed on the ASX on 7 August 2020.
4DX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About 4DMedical Limited
4DMedical Ltd (ASX: 4DX) is a medical technology company working in the field of respiratory imaging and ventilation analysis in the treatment of lung and respiratory diseases.
The company's non-invasive lung imaging technology emanates from research work undertaken at Monash University. It is the first FDA-cleared respiratory imaging solution that uses mathematical models and algorithms to convert sequences of X-ray images into four-dimensional quantitative data.
The technology uses existing imaging systems and allows X-ray images to be taken simultaneously from various angles. Using image-processing methods adapted from aerospace engineering, the motion of lung tissue can be measured. This allows ventilation to be calculated at each stage of the breath and at every location within the lung. These measurements are then visualized as a coloured heat map to help medical professionals accurately identify ventilation deficits.
The 4DMedical technology is patented in key jurisdictions, including the US and Australia. The company is aiming to secure a slice of the global lung imaging market. The US market alone was valued at more than $US30 billion in normal pre-COVID diagnostic conditions.
